Updates are available Correction dated 2024-03-25
Click to view Correction: https://doi.org/10.1186/s13024-024-00717-9
-
Authors
Martirosyan, Araks
Ansari, Rizwan
Pestana, Francisco
Hebestreit, Katja
Gasparyan, Hayk
Aleksanyan, Razmik
Hnatova, Silvia
Poovathingal, Suresh
Marneffe, Catherine
Thal, Dietmar R.
Kottick, Andrew
Hanson-Smith, Victor J.
Guelfi, Sebastian
Plumbly, William
Belgard, T. Grant
Metzakopian, Emmanouil http://orcid.org/0000-0003-2893-9741
Holt, Matthew G. http://orcid.org/0000-0002-8958-4027
-
Funding
Funding for this research was provided by:
Stichting Alzheimer Onderzoek (20200034, 2020/017)
Fundação para a Ciência e a Tecnologia (2020.08750BD)
Fonds Wetenschappelijk Onderzoek (G0F8516N, G065721N)
KU-Leuven Internal Funding (C14/17/107, C14/22/132, C3/20/057)
Bit Bio Ltd (RRAG/257)
Welcome Trust (RG86251)
Open Targets (OTAR2052)
European Commission (H2020 WIDESPREAD-2018-2020-6, NCBio, 951923)
UK Dementia Research Institute (RRZA/175)
VIB Tech Watch
- License Information
-
More Information
Article History
Received: 16 May 2023
Accepted: 14 December 2023
First Online: 20 January 2024
Change Date: 25 March 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13024-024-00717-9
Declarations
:
: The Ethics Committee of UZ Leuven/KU Leuven approved the use of human samples and gave ethical approval in line with the relevant Belgian legislation on privacy. Samples used in this study are registered in the UZ Leuven Biobank under the S-number S64182. Further details are available at
: T.G.B. is CEO of The Bioinformatics CRO and Senior Director of Bioinformatics at Bit.Bio. D.R.T. has received various honoraria related to speaking engagements from Biogen (USA) and UCB (Brussels, Belgium), and benefited from research collaborations with Novartis Pharma AG (Basel, Switzerland), Probiodrug (Halle (Saale), Germany), GE Healthcare (Amersham, UK), and Janssen Pharmaceuticals (Beerse, Belgium). E.M. is an employee and shareholder of Bit.Bio. M.G.H. acted as a paid consultant to Resolve Biosciences during development of their Molecular Cartography system. A.M. is currently an employee at Muna Therapeutics.
